|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The molecular biology of endome- trial cancers and the implications for pathogenesis, classification, and tar- geted therapies 显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 2 | The molecular biology of en- dometrial cancers and the implications for pathogenesis,classifica- tion, and targeted therapies 显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 3 | The molecular bi- ology of endometrial cancers and the implications for patho- genesis, classification, and targeted therapies 显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 4 | The molecular biology of endometrial cancers and the implications for pathogenesis, elassification, and targeted therapies显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 5 | Matrix metalloprotei- nase-1 gene promoter polymorphism and risk of ovarian eanc- er显示文摘 | Wenham RM Calinqaert B Ali S | 2003 | J Soc Gynecol Investiq2003，10，6： | 1 |
| 6 | The molecular biology of en- dometrial cancers and the implications for pathogenesis, classifica- tion and targeted therapies 显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 7 | The molecular biology of endometrial cancers and the implications for pathogenesis,classification,and targeted therapies显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 8 | The molecular biol ogy of endometrial cancers and the implications for pathogenesis classification, and targeted therapies显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 9 | The molecular biology of endometrial cancers and the implications for pathogenesis,classification,and targeted therapies显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，1： | 1 |
| 10 | Stage Ⅱ B-ⅣB cervical adenocarcinoma: prognostic factors and survival 显示文摘 | Lea JS Sheets EE Wenham RM | 2002 | Genocol Oncol2002，84，1： | 1 |
| 11 | The molecular biolo- gy of endometrial cancers and the implications for patho- genesis, classification, and targeted therapies 显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer Control2009，16，： | 1 |
| 12 | Stage ⅡB-ⅣB cervical adenocarcinoma: prognostic factors and survival显示文摘 | LeaJS Sheets EE Wenham RM | 2002 | Gynecol Oncol2002，84，1： | 1 |
| 13 | The molecular biolo-gy of endometrial cancers and the implications for patho*genesis, classification and targeted therapies 显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | CancerControl2009，16，1： | 1 |
| 14 | Randomized phase II trial of sorafenib alone or in combination with carboplatin/ paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer 显示文摘 | Schwandt A von Gruenigen VE Wenham RM | 2014 | Invest New Drugs2014，32，4： | 1 |
| 15 | A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within12 months of prior platinum-based chemotherapy显示文摘 | Wenham RM Lapolla J Lin HY | 2013 | Gynecol Oncol2013，130，1： | 1 |
| 16 | The molecular bi- ology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies显示文摘 | Bansal N Yendluri V Wenham RM | 2009 | Cancer control: journal of the Moffitt Cancer Center2009，16，1： | 1 |
| 17 | Stage Ⅱ B-Ⅳ B cervical adenocarcinoma:prognostic factors and survival显示文摘 | Lea JS Sheets EE Wenham RM | 2002 | Gynecol Oncol2002，84，1： | 1 |
| 18 | A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy显示文摘 | Wenham RM Lapolla J Lin HY | 2013 | Gynecol Oncol2013，130，1： | 1 |
| 19 | Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival显示文摘 | Lea JS Sheets EE Wenham RM | 2002 | Gynecol Oncol2002，84，1： | 1 |
| 20 | The molecular biology of endometrial cancers and the implications for pathogenesis,classification,and targeted therapies显示文摘 | Banshl N Yendluri V Wenham RM | 2009 | Cancer control2009，16，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员